{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:15:47Z","timestamp":1792955747269,"version":"4.5.0"},"reference-count":242,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113591","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:47:08Z","timestamp":1661147228000},"page":"113591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies"],"prefix":"10.1016","volume":"154","author":[{"given":"Prabhat","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Katila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hae","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12272-020-01259-6","article-title":"Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair","volume":"43","author":"Seo","year":"2020","journal-title":"Arch. Pharmacal Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/jnp.15.3.317","article-title":"Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review","volume":"15","author":"Nordahl","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1734-1140(09)70158-6","article-title":"Methamphetamine-induced neurotoxicity: the road to Parkinson\u2019s disease","volume":"61","author":"Thrash","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2022.113591_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2019.05.003","article-title":"Involvement of C\/EBP\u03b2-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis","volume":"312","author":"Huang","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib7","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s12272-020-01284-5","article-title":"PBN inhibits a detrimental effect of methamphetamine on brain endothelial cells by alleviating the generation of reactive oxygen species","volume":"43","author":"Hwang","year":"2020","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.biopha.2022.113591_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.toxlet.2020.06.016","article-title":"Transfer of pathological \u03b1-synuclein from neurons to astrocytes via exosomes causes inflammatory responses after METH exposure","volume":"331","author":"Meng","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfn263","article-title":"Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer","volume":"108","author":"Wells","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2022.113591_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.freeradbiomed.2015.07.157","article-title":"Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2","volume":"89","author":"Ramkissoon","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.113591_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6124745","article-title":"mTOR Modulates Methamphetamine-Induced Toxicity through Cell Clearing Systems","volume":"2018","author":"Lazzeri","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib12","first-page":"1784","article-title":"Structural abnormality of substantia nigra induced by methamphetamine abuse, Movement disorders: official journal of the Movement Disorder","volume":"32","author":"Rumpf","year":"2017","journal-title":"Society"},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1039\/C7TX00189D","article-title":"Role of GSK3\u03b2\/\u03b1-synuclein axis in methamphetamine-induced neurotoxicity in PC12 cells","volume":"7","author":"Li","year":"2017","journal-title":"Toxicol. Res (Camb. )"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101191","article-title":"The AKT modulator A-443654 reduces \u03b1-synuclein expression and normalizes ER stress and autophagy","volume":"297","author":"Gandelman","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2014.07.026","article-title":"S-nitrosylating protein disulphide isomerase mediates \u03b1-synuclein aggregation caused by methamphetamine exposure in PC12 cells","volume":"230","author":"Wu","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib16","first-page":"1386","article-title":"[Snitrosylating protein disulphide isomerase mediates increased expression of \u03b1 synuclein caused by methamphetamine in mouse brain]","volume":"37","author":"Wang","year":"2017","journal-title":"Nan Fang. yi ke da xue xue bao = J. South. Med. Univ."},{"key":"10.1016\/j.biopha.2022.113591_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuroscience.2019.03.016","article-title":"Effect of methamphetamine on rat primary midbrain cells; mitochondrial biogenesis as a compensatory response","volume":"406","author":"Valian","year":"2019","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2013.07.014","article-title":"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine","volume":"97","author":"Halpin","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113591_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1196\/annals.1369.003","article-title":"Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage","volume":"1074","author":"Kuhn","year":"2006","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbadis.2019.01.026","article-title":"Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E","volume":"1865","author":"Ambrogini","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2022.113591_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2017.03.009","article-title":"Methamphetamine: effects on the brain, gut and immune system","volume":"120","author":"Prakash","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.113591_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","article-title":"Amphetamine toxicities: classical and emerging mechanisms","volume":"1187","author":"Yamamoto","year":"2010","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12031-021-01886-8","article-title":"Elevation of Pro-inflammatory and Anti-inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury","volume":"72","author":"Kobeissy","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.athoracsur.2009.10.059","article-title":"Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest","volume":"89","author":"Tseng","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.biopha.2022.113591_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","article-title":"Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms","volume":"155","author":"Moratalla","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress\u2010induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib30","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ijms17091558","article-title":"ER stress-mediated signaling: Action potential and Ca2+ as key players","volume":"17","author":"Bahar","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib31","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","article-title":"ER stress-induced cell death mechanisms","volume":"1833","author":"Sano","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1096\/fj.03-0295com","article-title":"Cadet, Methamphetamine induces neuronal apoptosis via cross\u2010talks between endoplasmic reticulum and mitochondria\u2010dependent death cascades","volume":"18","author":"Jayanthi","year":"2004","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028946","article-title":"Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways","volume":"6","author":"Beauvais","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00213-022-06097-6","article-title":"Dopamine D1 receptors mediate methamphetamine-induced dopaminergic damage: involvement of autophagy regulation via the AMPK\/FOXO3A pathway","volume":"239","author":"He","year":"2022","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib35","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jcb.25795","article-title":"Escalating methamphetamine regimen induces compensatory mechanisms, mitochondrial biogenesis, and GDNF expression, in substantia Nigra","volume":"118","author":"Valian","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib36","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jcb.26398","article-title":"Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure","volume":"119","author":"Beirami","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuint.2007.06.014","article-title":"Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain","volume":"52","author":"Li","year":"2008","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib38","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ejn.13630","article-title":"Self-administration of methamphetamine alters gut biomarkers of toxicity","volume":"46","author":"Flack","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/ph14101003","article-title":"Inhibition of autophagy in vivo extends methamphetamine toxicity to mesencephalic cell bodies","volume":"14","author":"Ferrucci","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib40","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100188R","article-title":"Methamphetamine exposure induces neuronal programmed necrosis by activating the receptor-interacting protein kinase 3 -related signalling pathway","volume":"35","author":"Zhao","year":"2021","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib41","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ni.2159","article-title":"Programmed necrosis: backup to and competitor with apoptosis in the immune system","volume":"12","author":"Han","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113591_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2014.10.043","article-title":"Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine","volume":"745","author":"Jiang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/1673-5374.244795","article-title":"Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo","volume":"14","author":"Qiao","year":"2019","journal-title":"Neural Regen. Res"},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.brainresbull.2005.02.022","article-title":"Occurrence of neuronal inclusions combined with increased nigral expression of \u03b1-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice","volume":"65","author":"Fornai","year":"2005","journal-title":"Brain Res. Bull."},{"issue":"4\u20135","key":"10.1016\/j.biopha.2022.113591_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","article-title":"Environmental factors in Parkinson\u2019s disease","volume":"23","author":"Di Monte","year":"2002","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib47","first-page":"192","article-title":"Environment, mitochondria, and Parkinson's disease","volume":"8","author":"Sherer","year":"2002","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"14","key":"10.1016\/j.biopha.2022.113591_bib49","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib50","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/WNR.0000000000001495","article-title":"Role of alpha-synuclein phosphorylation at Serine 129 in methamphetamine-induced neurotoxicity in vitro and in vivo","volume":"31","author":"Ding","year":"2020","journal-title":"NeuroReport"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1352","article-title":"The role of chaperone\u2010mediated autophagy in neurotoxicity induced by alpha\u2010synuclein after methamphetamine exposure","volume":"9","author":"Sun","year":"2019","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib52","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1111\/ejn.12628","article-title":"Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking","volume":"40","author":"Kousik","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2007.03.073","article-title":"Zinc protects SK-N-SH cells from methamphetamine-induced \u03b1-synuclein expression","volume":"419","author":"Ajjimaporn","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2022.113591_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2019.05.035","article-title":"Methamphetamine persistently increases alpha-synuclein and suppresses gene promoter methylation within striatal neurons","volume":"1719","author":"Biagioni","year":"2019","journal-title":"Brain Res."},{"issue":"46","key":"10.1016\/j.biopha.2022.113591_bib55","doi-asserted-by":"crossref","first-page":"16884","DOI":"10.1523\/JNEUROSCI.3967-11.2011","article-title":"Authentically phosphorylated \u03b1-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease","volume":"31","author":"Sato","year":"2011","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib56","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1074\/jbc.M105326200","article-title":"Formation and removal of \u03b1-synuclein aggregates in cells exposed to mitochondrial inhibitors","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113591_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.toxlet.2019.11.028","article-title":"The effect of \u03b1-synuclein and Tau in methamphetamine induced neurotoxicity in vivo and in vitro","volume":"319","author":"Ding","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib58","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"issue":"19","key":"10.1016\/j.biopha.2022.113591_bib59","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.febslet.2012.06.040","article-title":"Methamphetamine binds to \u03b1-synuclein and causes a conformational change which can be detected by nanopore analysis","volume":"586","author":"Tavassoly","year":"2012","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib60","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2010.07147.x","article-title":"Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo","volume":"116","author":"Moszczynska","year":"2011","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib61","article-title":"The ubiquitin-proteasome system: potential therapeutic targets for Alzheimer\u2019s disease and spinal cord injury","volume":"9","author":"Gong","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib62","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/hmg\/ddy365","article-title":"Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies","volume":"28","author":"Liu","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"49","key":"10.1016\/j.biopha.2022.113591_bib63","doi-asserted-by":"crossref","first-page":"47870","DOI":"10.1074\/jbc.M203159200","article-title":"Parkin accumulation in aggresomes due to proteasome impairment","volume":"277","author":"Junn","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.biopha.2022.113591_bib64","doi-asserted-by":"crossref","first-page":"28572","DOI":"10.1074\/jbc.M200666200","article-title":"Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome","volume":"277","author":"Hyun","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.biopha.2022.113591_bib65","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an \u03b1-synuclein rat model of Parkinson's disease","volume":"101","author":"Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1574","article-title":"Effect of Parkin on methamphetamine\u2010induced \u03b1\u2010synuclein degradation dysfunction in vitro and in vivo","volume":"10","author":"Meng","year":"2020","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib67","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/ijms23010363","article-title":"Dopamine and methamphetamine differentially affect electron transport chain complexes and parkin in rat striatum: new insight into methamphetamine neurotoxicity","volume":"23","author":"Bazylianska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(80)91265-2","article-title":"Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine","volume":"181","author":"Wagner","year":"1980","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12640-009-9106-1","article-title":"Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration","volume":"18","author":"Granado","year":"2010","journal-title":"Neurotox. Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib70","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib71","first-page":"526","article-title":"Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration","volume":"9","author":"Lud Cadet","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord. )"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","article-title":"Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA","volume":"42","author":"Granado","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/syn.20185","article-title":"Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors","volume":"58","author":"Xu","year":"2005","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2009.05.002","article-title":"Nanotechnological applications for the treatment of neurodegenerative disorders","volume":"88","author":"Modi","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/1061186X.2011.607499","article-title":"Nanotherapeutics for Alzheimer\u2019s disease (AD): past, present and future","volume":"20","author":"Fazil","year":"2012","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","article-title":"Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology, N-methyl-D-aspartate receptors, tau protein and other risk factors","volume":"15","author":"Kocahan","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.biopha.2022.113591_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/247150","article-title":"Synapses and dendritic spines as pathogenic targets in Alzheimer's disease","volume":"2012","author":"Yu","year":"2012","journal-title":"Neural Plast."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib79","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11064-013-1051-y","article-title":"Effects of NMDA receptor blockade during the early development period on the retest performance of adult Wistar rats in the elevated plus maze","volume":"38","author":"Kocahan","year":"2013","journal-title":"Neurochem Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine--searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"S1","key":"10.1016\/j.biopha.2022.113591_bib81","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/gps.934","article-title":"Glutamatergic systems in Alzheimer's disease","volume":"18","author":"Francis","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib82","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1096\/fasebj.4.10.2165009","article-title":"Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?","volume":"4","author":"Palmer","year":"1990","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib83","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-\u03b2 peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J. Neurochem"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib84","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.conb.2011.09.001","article-title":"New developments on the role of NMDA receptors in Alzheimer's disease","volume":"22","author":"Malinow","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib85","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005777","article-title":"Synapses and Alzheimer's disease","volume":"4","author":"Sheng","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib86","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib87","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.stem.2009.10.003","article-title":"Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease","volume":"5","author":"Sun","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"26","key":"10.1016\/j.biopha.2022.113591_bib89","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","article-title":"Structural abnormalities in the brains of human subjects who use methamphetamine","volume":"24","author":"Thompson","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-3223(02)01442-7","article-title":"Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation","volume":"53","author":"Paulus","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib91","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/brain\/awn278","article-title":"Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study","volume":"131","author":"de Jong","year":"2008","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib92","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neurobiolaging.2010.05.002","article-title":"3D maps localize caudate nucleus atrophy in 400 Alzheimer\u2019s disease, mild cognitive impairment, and healthy elderly subjects","volume":"31","author":"Madsen","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib93","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2012.09.039","article-title":"Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine","volume":"530","author":"Feier","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2022.113591_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuro.2013.02.007","article-title":"NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats","volume":"36","author":"Bu","year":"2013","journal-title":"Neurotoxicology"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib95","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1360-0443.2011.03433.x","article-title":"Methamphetamine users show greater than normal age-related cortical gray matter loss","volume":"106","author":"Nakama","year":"2011","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib96","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2007.09.044","article-title":"Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory","volume":"150","author":"Simoes","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib97","first-page":"1","article-title":"miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113591_bib98","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2007.04.056","article-title":"Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures","volume":"1157","author":"Smith","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2022.113591_bib99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnins.2015.00069","article-title":"Methamphetamine effects on blood-brain barrier structure and function","volume":"9","author":"Northrop","year":"2015","journal-title":"Front Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib100","doi-asserted-by":"crossref","DOI":"10.1007\/BF02854904","article-title":"Causes and consequences of methamphetamine and MDMA toxicity","volume":"8","author":"Quinton","year":"2006","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib101","article-title":"Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine","volume":"6","author":"Abdul","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2022.113591_bib102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2011.07.013","article-title":"Methamphetamine transiently increases the blood\u2013brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9","volume":"1411","author":"Martins","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2022.113591_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101062","article-title":"The multi-faceted impact of methamphetamine on Alzheimer\u2019s disease: from a triggering role to a possible therapeutic use","volume":"60","author":"Shukla","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib104","article-title":"Chronic methamphetamine increases alpha-synuclein protein levels in the striatum and hippocampus but not in the cortex of juvenile mice","volume":"2","author":"Butler","year":"2014","journal-title":"J. Addict. Prev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171925","article-title":"\u03b1-Synuclein increases \u03b2-amyloid secretion by promoting \u03b2-\/\u03b3-secretase processing of APP","volume":"12","author":"Roberts","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2022.113591_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4982453","article-title":"Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress","volume":"2018","author":"Limanaqi","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/NMM:2:1:71","article-title":"Methamphetamine-induced TNF-\u03b1 gene expression and activation of AP-1 in discrete regions of mouse brain","volume":"2","author":"Flora","year":"2002","journal-title":"Neuromole. Med."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103067","article-title":"Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer's disease","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120352","article-title":"Assembly and interrogation of Alzheimer\u2019s disease genetic networks reveal novel regulators of progression","volume":"10","author":"Aubry","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034236","article-title":"Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation\/hypoacetylation in the rat nucleus accumbens","volume":"7","author":"Martin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113591_bib111","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-2009-1134","article-title":"Dysregulation of histone acetylation in the APP\/PS1 mouse model of Alzheimer's disease","volume":"18","author":"Francis","year":"2009","journal-title":"J. Alzheimer'S. Dis."},{"issue":"19","key":"10.1016\/j.biopha.2022.113591_bib112","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1074\/jbc.M112.381392","article-title":"MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10)","volume":"288","author":"Cheng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib113","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11481-016-9671-z","article-title":"Decreased expression of plasma microRNA in patients with methamphetamine (MA) use disorder","volume":"11","author":"Zhao","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib114","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/MCB.05896-11","article-title":"Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons","volume":"32","author":"Saba","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib115","first-page":"1","article-title":"mRNA changes in nucleus accumbens related to methamphetamine addiction in mice","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib116","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ncb1876","article-title":"A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis","volume":"11","author":"Siegel","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib117","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1007\/s11010-021-04160-y","article-title":"Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity","volume":"476","author":"Gu","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12868-015-0157-3","article-title":"Methamphetamine induces alterations in the long non-coding RNAs expression profile in the nucleus accumbens of the mouse","volume":"16","author":"Zhu","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.biopha.2022.113591_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135050","article-title":"Knockdown of circHomer1 ameliorates METH-induced neuronal injury through inhibiting Bbc3 expression","volume":"732","author":"Li","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"17","key":"10.1016\/j.biopha.2022.113591_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179205","article-title":"Gender-dependent deregulation of linear and circular RNA Variants of HOMER1 in the entorhinal cortex of Alzheimer's disease","volume":"22","author":"Urd\u00e1noz-Casado","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib121","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1080\/15548627.2017.1356975","article-title":"Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG","volume":"13","author":"Huang","year":"2017","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib122","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1038\/s41419-017-0017-4","article-title":"circHIPK2-mediated \u03c3-1R promotes endoplasmic reticulum stress in human pulmonary fibroblasts exposed to silica","volume":"8","author":"Cao","year":"2017","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib123","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2131\/jts.44.493","article-title":"Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line","volume":"44","author":"Chen","year":"2019","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib124","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awz026","article-title":"Functional connectivity associated with tau levels in ageing, Alzheimer\u2019s, and small vessel disease","volume":"142","author":"Franzmeier","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib126","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2008.05673.x","article-title":"Role of histamine in short- and long-term effects of methamphetamine on the developing mouse brain","volume":"107","author":"Acevedo","year":"2008","journal-title":"J. Neurochem"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib127","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0306-4522(02)00795-9","article-title":"Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain","volume":"116","author":"Wallace","year":"2003","journal-title":"Neuroscience"},{"issue":"17","key":"10.1016\/j.biopha.2022.113591_bib128","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2022.113591_bib129","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2022.113591_bib131","author":"Fleming","year":"2019","journal-title":"Atyp. Psychiatr. symptoms Presence Huntingt. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib132","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00415-012-6415-8","article-title":"Substance abuse may be a risk factor for earlier onset of Huntington disease","volume":"259","author":"Byars","year":"2012","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib133","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.freeradbiomed.2010.02.023","article-title":"HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: Potential role of the thiol antioxidant N-acetylcysteine amide","volume":"48","author":"Banerjee","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(24)37769-9","article-title":"The effects of methamphetamine on the production of free radicals and oxidative stress","volume":"287","author":"Yamamoto","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib135","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999","article-title":"Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine","volume":"19","author":"LaVoie","year":"1999","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib136","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2005.03.031","article-title":"HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells","volume":"1045","author":"Price","year":"2005","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib137","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0304-3940(02)00814-5","article-title":"Circulating gp120 alters the blood\u2013brain barrier permeability in HIV-1 gp120 transgenic mice","volume":"330","author":"Cioni","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib138","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000066967","article-title":"Junctional adhesion molecules and interendothelial junctions","volume":"172","author":"Aurrand-Lions","year":"2002","journal-title":"Cells Tissues Organs"},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib139","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1083\/jcb.143.2.391","article-title":"A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts","volume":"143","author":"Furuse","year":"1998","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib140","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","article-title":"Methamphetamine-related stroke: four cases","volume":"17","author":"Perez","year":"1999","journal-title":"J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.brainresbull.2005.07.012","article-title":"Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells","volume":"67","author":"Ajjimaporn","year":"2005","journal-title":"Brain Res. Bull."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113591_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(94)02949-U","article-title":"Oxidant resistance of cadmium-adapted human lung fibroblasts","volume":"98","author":"Hart","year":"1995","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib144","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-4838(85)90098-6","article-title":"Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals","volume":"827","author":"Thornalley","year":"1985","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Protein Struct. Mol. Enzymol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib145","first-page":"111","article-title":"Protective effects of cadmium chloride against UVB injury in mouse skin and in cultured human cells: a possible role of cadmium-induced metallothionein","volume":"8","author":"Hanada","year":"1991","journal-title":"Photodermatol., Photoimmunol. Photomed."},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib146","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","article-title":"Ascorbate regulation and its neuroprotective role in the brain","volume":"23","author":"Rice","year":"2000","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib147","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nm0502-445","article-title":"New view at C","volume":"8","author":"Hediger","year":"2002","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib148","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.taap.2012.08.036","article-title":"l-Ascorbate attenuates methamphetamine neurotoxicity through enhancing the induction of endogenous heme oxygenase-1","volume":"265","author":"Huang","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib149","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12035-015-9561-z","article-title":"L-Ascorbate protects against methamphetamine-induced neurotoxicity of cortical cells via inhibiting oxidative stress, autophagy, and apoptosis","volume":"54","author":"Huang","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib150","first-page":"11","article-title":"Anthocyanin as neuroprotector for methamphetamine-induced neurotoxicity","volume":"3","author":"Primatanti","year":"2019","journal-title":"Int. J. Health Med. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib151","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/jsfa.2964","article-title":"Cytoprotective effects of anthocyanins and other phenolic fractions of Boysenberry and blackcurrant on dopamine and amyloid \u03b2\u2010induced oxidative stress in transfected COS\u20107 cells","volume":"87","author":"Ghosh","year":"2007","journal-title":"J. Sci. Food Agric."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2022.113591_bib152","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tox.2006.06.015","article-title":"Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum","volume":"226","author":"Wu","year":"2006","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib153","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1254\/jphs.09153SC","article-title":"Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice","volume":"111","author":"Lee","year":"2009","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib154","first-page":"135","article-title":"Protective effect of cinnamaldehyde on METH-induced neurotoxicity in PC12 cells via inhibition of apoptotic response and oxidative stress","volume":"20","author":"Rashidi","year":"2021","journal-title":"Iran. J. Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/1735-5362.319577","article-title":"Thymoquinone abrogates methamphetamine-induced striatal neurotoxicity and hyperlocomotor activity in mice","volume":"16","author":"Roohbakhsh","year":"2021","journal-title":"Res Pharm. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib156","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3390\/molecules26092442","article-title":"6, 7, 4\u2032-Trihydroxyflavanone mitigates methamphetamine-induced neurotoxicity in SH-SY5y cells via Nrf2\/heme oxyganase-1 and PI3K\/Akt\/mTOR signaling pathways","volume":"26","author":"Lee","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib157","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/ijms22052274","article-title":"Aromadendrin protects neuronal cells from methamphetamine-induced neurotoxicity by regulating endoplasmic reticulum stress and PI3K\/Akt\/mTOR signaling pathway","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib158","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.06.030","article-title":"Effect of \u03b1-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity","volume":"1109","author":"Park","year":"2006","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib159","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1989.tb14904.x","article-title":"Vitamin E as an in vitro and in vivo antioxidant a","volume":"570","author":"Burton","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.taap.2003.12.017","article-title":"Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells","volume":"196","author":"Jim\u00e9nez","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib161","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1203\/01.PDR.0000081297.53793.C6","article-title":"Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia","volume":"54","author":"Peeters-Scholte","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.biopha.2022.113591_bib162","first-page":"25","article-title":"Antioxidant properties of propofol when oxidative stress sleeps with patients","volume":"5","author":"Volti","year":"2006","journal-title":"Excli J."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib163","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0971-6580.172250","article-title":"Protective effects of propofol against methamphetamine-induced neurotoxicity","volume":"22","author":"Shokrzadeh","year":"2015","journal-title":"Toxicol. Int."},{"key":"10.1016\/j.biopha.2022.113591_bib164","doi-asserted-by":"crossref","first-page":"7478523","DOI":"10.1155\/2017\/7478523","article-title":"Supplementation of micronutrient selenium in metabolic diseases: its role as an antioxidant","volume":"2017","author":"Wang","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(99)02122-8","article-title":"Protection of methamphetamine nigrostriatal toxicity by dietary selenium","author":"Kim","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib166","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0006-8993(98)01311-0","article-title":"Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity","volume":"818","author":"Imam","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2022.113591_bib167","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuro.2013.05.009","article-title":"Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium","volume":"37","author":"Barayuga","year":"2013","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib168","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/13880209.2014.931440","article-title":"Attenuation of cyclophosphamide-induced pulmonary toxicity in Swiss albino mice by naphthalimide-based organoselenium compound 2-(5-selenocyanatopentyl)-benzo[de]isoquinoline 1,3-dione","volume":"53","author":"Ghosh","year":"2015","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib169","doi-asserted-by":"crossref","first-page":"245","DOI":"10.17219\/acem\/67222","article-title":"Selenium - a fascinating antioxidant of protective properties","volume":"27","author":"Kie\u0142czykowska","year":"2018","journal-title":"Adv. Clin. Exp. Med"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2022.113591_bib170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(98)00300-0","article-title":"Talipexole protects dopaminergic neurons from methamphetamine toxicity in C57BL\/6N mouse","volume":"247","author":"Kondo","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib171","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03258445","article-title":"Preliminary study of B-HT 920, a novel dopamine agonist, for the treatment of Parkinson\u2019s disease","volume":"5","author":"Mizuno","year":"1993","journal-title":"Drug Investig."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib172","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ejn.13363","article-title":"Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence","volume":"45","author":"Kish","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2022.113591_bib173","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2016.05.003","article-title":"Melatonin prevents cytosolic calcium overload, mitochondrial damage and cell death due to toxically high doses of dexamethasone-induced oxidative stress in human neuroblastoma SH-SY5Y cells","volume":"97","author":"Suwanjang","year":"2016","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib174","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jpi.12310","article-title":"Melatonin prevents abnormal mitochondrial dynamics resulting from the neurotoxicity of cadmium by blocking calcium-dependent translocation of Drp1 to the mitochondria","volume":"60","author":"Xu","year":"2016","journal-title":"J. Pineal Res"},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib175","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jpi.12225","article-title":"Melatonin attenuates methamphetamine-induced inhibition of proliferation of adult rat hippocampal progenitor cells in vitro","volume":"58","author":"Ekthuwapranee","year":"2015","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib176","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s12640-022-00522-6","article-title":"Melatonin attenuates methamphetamine-induced alteration of amyloid \u03b2 precursor protein cleaving enzyme expressions via melatonin receptor in human neuroblastoma cells","volume":"40","author":"Nopparat","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2022.113591_bib177","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-10-91","article-title":"Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial","volume":"10","author":"Berk","year":"2012","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib178","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib179","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0033291716002932","article-title":"Cognitive effects of adjunctive N-acetyl cysteine in psychosis","volume":"47","author":"Rapado-Castro","year":"2017","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/dar.12414","article-title":"A potential role for N-acetylcysteine in the management of methamphetamine dependence","volume":"36","author":"McKetin","year":"2017","journal-title":"Drug Alcohol Rev."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib181","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1073858413520347","article-title":"Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis","volume":"20","author":"Scofield","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.biopha.2022.113591_bib182","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1196\/annals.1316.028","article-title":"Effects of N-acetyl-L-cysteine on the reduction of brain dopamine transporters in monkey treated with methamphetamine","volume":"1025","author":"Hashimoto","year":"2004","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2022.113591_bib183","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1177\/0960327112438287","article-title":"N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice","volume":"31","author":"Zhang","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib184","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1476-5381.1993.tb12847.x","article-title":"Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine","volume":"108","author":"Baldwin","year":"1993","journal-title":"Br. J. Pharm."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113591_bib185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2012.10.009","article-title":"Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis","volume":"130","author":"Ma","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib186","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.neuropharm.2012.02.015","article-title":"Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures","volume":"62","author":"Baptista","year":"2012","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.biopha.2022.113591_bib187","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1021\/acschemneuro.1c00373","article-title":"Tetrahydropalmatine regulates BDNF through TrkB\/CAM interaction to alleviate the neurotoxicity induced by methamphetamine","volume":"12","author":"Liu","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib188","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S1461145708009802","article-title":"Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage","volume":"12","author":"Bachmann","year":"2009","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib189","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pbb.2012.09.010","article-title":"Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine","volume":"103","author":"Feier","year":"2013","journal-title":"Pharm. Biochem Behav."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib190","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.42.11.2147","article-title":"MELAS syndrome with mitochondrial tRNA Leu [UUR] mutation: Correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin","volume":"42","author":"Penn","year":"1992","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib191","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/00001756-199705260-00018","article-title":"Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats","volume":"8","author":"Huang","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2022.113591_bib192","article-title":"Oxytocin attenuates methamphetamine-induced apoptosis via oxytocin receptor in rat hippocampal neurons","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113591_bib193","series-title":"Methamphetamine Neurotoxicity and Neuroinflammatory Processes, Neuroinflammation and Neurodegeneration","first-page":"443","author":"Northrop","year":"2014"},{"issue":"22","key":"10.1016\/j.biopha.2022.113591_bib194","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"issue":"2015)","key":"10.1016\/j.biopha.2022.113591_bib195","article-title":"Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology","author":"Yu","year":"2015","journal-title":"Behav. Neurol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib196","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib197","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.pnpbp.2006.05.015","article-title":"Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine","volume":"30","author":"Zhang","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113591_bib198","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.04.010","article-title":"The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse","volume":"637","author":"Beardsley","year":"2010","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113591_bib199","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugalcdep.2015.04.012","article-title":"Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats","volume":"152","author":"Charntikov","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046599","article-title":"Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum","volume":"7","author":"Raineri","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib201","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1166\/jnn.2009.GR04","article-title":"Nano-drug delivery and neuroprotection in spinal cord injury","volume":"9","author":"Sharma","year":"2009","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113591_bib202","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1517\/17425255.2014.970168","article-title":"Development of in vivo drug-induced neurotoxicity models","volume":"10","author":"Sharma","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jpi.12195","article-title":"Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKC\u03b4 gene","volume":"58","author":"Nguyen","year":"2015","journal-title":"J. Pineal Res"},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib204","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1166\/jnn.2009.GR10","article-title":"Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290\/51","volume":"9","author":"Sharma","year":"2009","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.biopha.2022.113591_bib205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.talanta.2017.07.011","article-title":"A novel colorimetric biosensor based on non-aggregated Au@ Ag core\u2013shell nanoparticles for methamphetamine and cocaine detection","volume":"175","author":"Mao","year":"2017","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib206","first-page":"305","article-title":"Pharmacological treatments for methamphetamine addiction: current status and future directions","volume":"10","author":"Ballester","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113591_bib207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2016.08.001","article-title":"The neurocircuitry involved in oxytocin modulation of methamphetamine addiction","volume":"43","author":"Baracz","year":"2016","journal-title":"Front. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib208","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib209","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","article-title":"Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats","volume":"6","author":"Gentry","year":"2006","journal-title":"Int Immunopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib210","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1124\/dmd.114.056879","article-title":"Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy","volume":"42","author":"White","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib211","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.jmedchem.5b00220","article-title":"Combining active immunization with monoclonal antibody therapy to facilitate early initiation of a long-acting anti-methamphetamine antibody response","volume":"58","author":"Hambuchen","year":"2015","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113591_bib212","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jfda.2013.09.040","article-title":"Treatment of methamphetamine abuse: an antibody-based immunotherapy approach","volume":"21","author":"Chen","year":"2013","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biopha.2022.113591_bib213","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2013.08.009","article-title":"Inhibition of ROCK2 expression protects against methamphetamine-induced neurotoxicity in PC12 cells","volume":"1533","author":"Yang","year":"2013","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib214","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/exnr.1998.7002","article-title":"The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis","volume":"155","author":"Yu","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2022.113591_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111945","article-title":"Glutathione peroxidase-1 and neuromodulation: Novel potentials of an old enzyme","volume":"148","author":"Sharma","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2022.113591_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112313","article-title":"GPx-1-encoded adenoviral vector attenuates dopaminergic impairments induced by methamphetamine in GPx-1 knockout mice through modulation of NF-\u03baB transcription factor","volume":"154","author":"Sharma","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib217","first-page":"851","article-title":"Ubiquitin-protein ligase parkin and its role in the development of Parkinson\u2019s disease","volume":"71","author":"Buneeva","year":"2006","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1669","article-title":"Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells","volume":"3","author":"Jiang","year":"2012","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib219","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2011.05.116","article-title":"Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin","volume":"410","author":"Yang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2007.06.019","article-title":"rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease","volume":"207","author":"Manfredsson","year":"2007","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib221","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","article-title":"Parkin gene therapy for \u03b1-synucleinopathy: a rat model of Parkinson's disease","volume":"16","author":"Yamada","year":"2005","journal-title":"Hum. gene Ther."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib222","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2006.03.001","article-title":"Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model","volume":"401","author":"Klein","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2022.113591_bib223","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an \u03b1-synuclein rat model of Parkinson's disease","author":"Lo Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.biopha.2022.113591_bib224","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1523\/JNEUROSCI.3597-04.2004","article-title":"High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity","volume":"24","author":"Mark","year":"2004","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2022.113591_bib225","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1567-5769(02)00047-4","article-title":"Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice","volume":"2","author":"Yu","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxlet.2008.01.005","article-title":"Protective effects of interferon-\u03b3 against methamphetamine-induced neurotoxicity","volume":"177","author":"Hozumi","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib227","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","article-title":"Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures","volume":"19","author":"Nagayama","year":"1999","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2022.113591_bib228","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.0953-816x.2001.01536.x","article-title":"Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity","volume":"13","author":"Hampson","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"6855","key":"10.1016\/j.biopha.2022.113591_bib229","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113591_bib231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098079","article-title":"\u03949-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity","volume":"9","author":"Castelli","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib232","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.06578.x","article-title":"Evidence that MDMA (\u2018ecstasy\u2019) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain","volume":"113","author":"Torres","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2022.113591_bib233","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbr.2013.08.033","article-title":"Effects of cholecystokinin-8 on morphine-induced spatial reference memory impairment in mice","volume":"256","author":"Yang","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113591_bib234","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-8993(02)04051-9","article-title":"Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism","volume":"963","author":"Helm","year":"2003","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.113591_bib235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/shk.0b013e3180ze26dd","article-title":"CCK-8 inhibits LPS-induced IL-1\u03b2 production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-\u03baB pathway","volume":"27","author":"Li","year":"2007","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.biopha.2022.113591_bib236","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-010-1476-4","article-title":"Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses","volume":"31","author":"Li","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2022.113591_bib237","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbr.2015.01.028","article-title":"Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice","volume":"283","author":"Gou","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113591_bib238","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12640-013-9413-4","article-title":"9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons","volume":"25","author":"Reiner","year":"2014","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113591_bib239","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-013-3221-7","article-title":"7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine","volume":"231","author":"Ren","year":"2014","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2022.113591_bib240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12640-019-00050-w","article-title":"Pifithrin-alpha reduces methamphetamine neurotoxicity in cultured dopaminergic neurons","volume":"36","author":"Chen","year":"2019","journal-title":"Neurotox. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.113591_bib241","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1007\/s11033-021-06741-y","article-title":"Possible repair mechanisms of renin-angiotensin system inhibitors, matrix metalloproteinase-9 inhibitors and protein hormones on methamphetamine-induced neurotoxicity","volume":"48","author":"Zhao","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"13","key":"10.1016\/j.biopha.2022.113591_bib242","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"Jama"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:27:43Z","timestamp":1791660463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222009805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":242,"alternative-id":["S0753332222009805"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113591","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113591"}}